NO941458L - - Google Patents

Info

Publication number
NO941458L
NO941458L NO941458A NO941458A NO941458L NO 941458 L NO941458 L NO 941458L NO 941458 A NO941458 A NO 941458A NO 941458 A NO941458 A NO 941458A NO 941458 L NO941458 L NO 941458L
Authority
NO
Norway
Prior art keywords
burgdorferi
polypeptide
relates
lyme
disease
Prior art date
Application number
NO941458A
Other languages
English (en)
Norwegian (no)
Other versions
NO941458D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/781,355 external-priority patent/US5246844A/en
Application filed filed Critical
Publication of NO941458D0 publication Critical patent/NO941458D0/no
Publication of NO941458L publication Critical patent/NO941458L/no

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
NO941458A 1991-10-22 1994-04-21 Virulensbetingende proteiner i Borrelia Burgdorferi (Bb) NO941458D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/781,355 US5246844A (en) 1991-10-22 1991-10-22 Virulence associated proteins in borrelia burgdorferi (bb)
PCT/US1992/009145 WO1993008286A1 (en) 1991-10-22 1992-10-21 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb)

Publications (2)

Publication Number Publication Date
NO941458D0 NO941458D0 (no) 1994-04-21
NO941458L true NO941458L (da) 1994-04-21

Family

ID=26785129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941458A NO941458D0 (no) 1991-10-22 1994-04-21 Virulensbetingende proteiner i Borrelia Burgdorferi (Bb)

Country Status (1)

Country Link
NO (1) NO941458D0 (da)

Also Published As

Publication number Publication date
NO941458D0 (no) 1994-04-21

Similar Documents

Publication Publication Date Title
CN1328286C (zh) 无糖产物和使用方法
Darcy et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
DE69737125T3 (de) Streptococcus pneumoniae-Antigene und Impfstoffe
ATE210296T1 (de) Immunologisches nachweisverfahren von antikörpern,die gegen gewebe-transglutaminase (ttg) gerichtet sind, verwendung von ttg zur diagnose und therapiekontrolle sowie orales pharmazeutisches mittel enthaltend ttg
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
US20030044429A1 (en) Toll-like receptor 5 ligands and methods of use
DE60139690D1 (de) Immunisierung gegen chlamydia pneumoniae
WO1995014781A3 (en) Methods for diagnosing early lyme disease
DE60024092T2 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
MX2011000134A (es) Vacuna contra el intermediario de plegamiento amiloide.
CA2294701A1 (en) Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
EP0896583A1 (en) Novel osp-c derived peptide fragments
CN106794236A (zh) A群链球菌疫苗
Ewing et al. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27. 1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199).
JPH0710774A (ja) スプレプトコッカス・スイス感染に対するワクチン
JP2003520765A (ja) ポルフィロモナス・ジンジヴァリスによる歯周炎の治療及び予防のための保護エピトープを含有する合成ペプチド
SI0998556T1 (en) Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
PT1219301E (pt) Vacinas contendo polipéptidos híbridos, consistindo em, pelo menos, duas proteínas alergénicas diferentes
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
Parr et al. Purification and measurement of secretory IgA in mouse milk
WO2002081625A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
NO941458L (da)
WO2002099062A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US20040156865A1 (en) M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
WO2002090504A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use